Contract Services Clinical Research
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that the Company received marketing authorization in China from Natio...
January 24, 2025 | News
Allurion Technologies, Inc. (“Allurion” or the “Company”) (NYSE: ALUR), a company dedicated to ending obesity, today announced its ...
January 24, 2025 | News
Expecto Health Science, a leading full-service Contract Research Organization (CRO) in Asia Pacific with a focus on emerging economies, announced the signi...
January 24, 2025 | News
Guangzhou Fermion Technology Co., Ltd. and Simcere Pharmaceutical Group Limited have announced a partnership to develop a clinical-stage pain treatment ass...
January 20, 2025 | News
Collaboration enables insights from ConcertAI national database of 5.5M clinical records and Guardant profiling data across 60+ tumor types Longitudinal...
January 17, 2025 | News
Collaboration enables insights from ConcertAI national database of 5.5M clinical records and Guardant profiling data across 60+ tumor types Longitudinal...
January 17, 2025 | News
Marketing authorization application for BCG Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC) with Carcinoma in situ (CIS) submitted to Europ...
January 16, 2025 | News
Aragen, a globally renowned Contract Research, Development and Manufacturing Organization (CRDMO), announced that it has secured a $100 Mn investment...
January 13, 2025 | News
W Therapeutics (HKEx: 2126), an independent and innovative biotechnology company focused on developing, manufacturing and commercializing ce...
January 13, 2025 | News
Regor announced its 12-week single-dose Phase 2a trial results for RGT-075, a once-daily oral GLP-1RA, reporting 5% placebo-adjusted weight-loss with no ...
January 13, 2025 | News
The legacy of Duke-NUS' founding donor, the Estate of Khoo Teck Puat, continues with a transformative S$5.5 million gift towards research. The...
January 13, 2025 | News
Biofidelity, a leader in innovative genomic solutions, and CellCarta, the global contract research organization (CRO) partner of choice for biopharmac...
January 10, 2025 | News
In an exclusive interview with BioPharma APAC, Heather Hargett, Head of Cell Biology Reagents & Tools at MilliporeSigma ( Merck KGaA, Darmstadt, German...
January 10, 2025 | News
Givastomig: a Claudin 18.2 ("CLDN18.2") x 4-1BB bispecific antibody, will be the lead clinical program following the Company's portfolio prioritization ...
January 07, 2025 | News
Most Read
Bio Jobs
News
Editor Picks